Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Blood | September 25, 2013 | Volume: 122 | Issue: 24 | Pages: 3863-3870
10.1182/blood-2013-07-514448
| PMID 24065243
Key Points In combination with cyclophosphamide, intravenous busulfan is associated with better leukemia-free and overall survival in AML than TBI.